Publication & Citation Trends
Publications
0 total
INTERLEUKIN-1 RECEPTOR ANTAGONIST LEVELS IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED WITH ANAKINRA
Cited by 0
Semantic Scholar
Treatment of murine autoimmune myocarditis with a novel monoclonal antibody that targets multiple inflammatory pathways
Cited by 0
Semantic Scholar
26-A-18549-ACC PRESEPSIN AS A BIOMARKER OF CD14 PATHWAY ACTIVATION AND ITS MODULATION WITH ATIBUCLIMAB (IC14) IN ACUTE DECOMPENSATED HEART FAILURE
Cited by 0
Semantic Scholar
26-A-12298-ACC ATIBUCLIMAB (IC14) IN ACUTE DECOMPENSATED HEART FAILURE: RESULTS OF A PHASE 1B PILOT STUDY
Cited by 0
Semantic Scholar
Abstract 5226: The role of pancreatic adenocarcinoma cancer-stromal interactions on cardiac structure and function
Cited by 0
Semantic Scholar
Elevated Plasma IL-18 Levels During Chemotherapy Treatment for Breast Cancer, Exercise Capacity, and Physical Activity
Cited by 0
Semantic Scholar
Abstract Fri069: The RXFP1 Agonist ML290 Protects Against Doxorubicin-induced Cardiomyocyte Injury in vitro
Cited by 0
Semantic Scholar
Orally Delivered Milk-Derived Nanovesicles Loaded with Connexin 43 Peptides for Targeted Cardiac Ischemia-Reperfusion Therapy
Cited by 1
Semantic Scholar
UNCONVENTIONAL INTERLEUKIN-1 SIGNALING IN CARDIAC DYSFUNCTION
Cited by 0
Semantic Scholar
Research Topics
Inflammasome and immune disorders
(42)
Cardiac Fibrosis and Remodeling
(37)
Cardiac Ischemia and Reperfusion
(18)
Chemotherapy-induced cardiotoxicity and mitigation
(18)
Transplantation: Methods and Outcomes
(17)
Affiliations
Johnson & Johnson (United States)
University of Trieste
Virginia Union University
Virginia Commonwealth University
University Health System